Topical tacrolimus versus dexamethasone in managing shield ulcer of vernal keratoconjunctivitis.

Both groups experienced a decreasing trend in frequencies of all symptoms, and at most follow-up visits, ocular symptoms were less frequent in the tacrolimus group than in the dexamethasone group, reaching statistically significant differences at some time points (all P < 0.05).

also in 47,180 other papers

However, an increasing trend was observed thereafter in both groups, with significantly more re-epithelialization in tacrolimus-treated eyes at the second and third months post-treatment ( P < 0.05).

also in 63,971 other papers